Literature DB >> 4001725

Universal immunization to interrupt rubella.

K J Bart, W A Orenstein, S R Preblud, A R Hinman.   

Abstract

The aim of universal immunization is to control congenital rubella syndrome by interrupting transmission of rubella virus among young children through immunization of all children, male and female, on or after their first birthday, thereby decreasing the chances that a susceptible pregnant woman would be exposed to the virus. Concerns about rubella vaccine (durability of protection, safety, and communicability) no longer determine the choice of universal vs. selective immunization. Rather, the cost of vaccine, the accessibility of the target populations, and the vaccine coverage attainable in practice influence the choice of strategy. Either universal or selective immunization should, if properly implemented, eventually control rubella and congenital rubella infection. However, the choice of universal immunization recognizes the difficulty involved in immunizing 100% of the women of childbearing age, and the universal strategy offers the advantage of rapidly reducing congenital rubella infection by interrupting transmission and provides early protection to unvaccinated individuals by reducing their risk of exposure.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4001725     DOI: 10.1093/clinids/7.supplement_1.s177

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

1.  Vaccination policies: individual rights v community health. We can't afford to be half hearted about vaccination programmes.

Authors:  S King
Journal:  BMJ       Date:  1999-12-04

Review 2.  Rational use of measles, mumps and rubella (MMR) vaccine.

Authors:  H Carter; H Campbell
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

3.  Say Yes to MMR: Ethical, Scientific and Practical Reasons.

Authors:  R P Singh Tomar
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  Preventing rubella: assessing missed opportunities for immunization.

Authors:  S E Robertson; S L Cochi; G A Bunn; D L Morse; S R Preblud
Journal:  Am J Public Health       Date:  1987-10       Impact factor: 9.308

Review 5.  Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review.

Authors:  T Panagiotopoulos; I Antoniadou; E Valassi-Adam
Journal:  BMJ       Date:  1999-12-04

6.  Seroepidemiology, morbidity and vaccination strategies against rubella infection. Eight years experience in Oltrepò Pavese.

Authors:  C Pelissero; C Marena; F Aguzzi; M Bevilacqua; F Rebasti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

7.  Policies for immunization against rubella in European countries.

Authors:  I De la Mata; P De Wals
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.